|
Company Overview:
Simpson Biotech Co., Ltd. (SBC) is a bio-fermentation company established in 1998. SBC currently focuses on (i) protein expression & purification techniques used for the production of biosimilars and industrial enzymes, (ii) fermentation and applications of mycelia from several medicinal fungi and early stage drug discovery from these mycelia products.
Employees: 34
Industry Sectors:
l Biotechnology Company
l Early Stage Drug Discovery
l Food and Agriculture
l Contract Manufacturing
l Platform Technologies
Capital: 10 millions US Dollars
Major Products/Services:
1. HERPEPSTM: (High Efficiency Recombinant Protein Expression and Purification System) and recombinant proteins OEM/ODM fermentation services/Contract manufacturing including biosimilar production license
2. Antrodia camphorata mycelia (ACM) by fermentation: A hepatoprotective fungus (Ruby Mushroom®) exclusively from Taiwan
3. Early stage drug discovery from medicinal fungi and their pre-clinical studies thereof
l Hepasim®: The major active compounds isolated from ACM with potent anti-virus (HCV/HBV), hepatoprotective, anti-fibrosis, anti-inflammation and anti-tumor activities
l CamphoratanTM A: The 2nd active compound (polysaccharide) isolated and identified from ACM with strong anti-fulminant hepatic injury activities
4. Other medicinal mushroom mycelia by fermentation:
l Cordyceps sinensis, Phellinus linteus, Ganoderma lucidum, Agaricus blazei murill: Mycelia and their extracts
l Ruby MaleMaxTM: Male hormone (testosterone) stimulator isolated from Cordyceps sinensis mycelia (CSM)
l Ruby ImmuSimTM: Immune booster isolated from CSM
l Ruby OsteosimTM: Anti-osteoporosis (US Pat. 7,311,919) supplement isolated from CSM
5. Industrial enzymes: phytase, xylanase (animal feed), lipase (biodiesel, food additives) etc.
|
